The management of chronic and acute moderate-to-severe pain remains one of the most complex challenges in modern clinical medicine. Traditional full mu-opioid receptor agonists, while historically effective, present significant physiological risks, including profound respiratory depression, rapid tolerance development, and high liability for dependence. In response to these limitations, medical science has increasingly turned to alternative […]